Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:37:04 UTC |
---|
Update Date | 2021-09-26 23:17:31 UTC |
---|
HMDB ID | HMDB0259762 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Vaniprevir |
---|
Description | 21-tert-butyl-N-{1-[(cyclopropanesulfonyl)-C-hydroxycarbonimidoyl]-2-ethylcyclopropyl}-19-hydroxy-16,16-dimethyl-3,22-dioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1⁴,⁷.0⁶,¹¹]heptacosa-6(11),7,9,19-tetraene-24-carboximidic acid belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. Based on a literature review very few articles have been published on 21-tert-butyl-N-{1-[(cyclopropanesulfonyl)-C-hydroxycarbonimidoyl]-2-ethylcyclopropyl}-19-hydroxy-16,16-dimethyl-3,22-dioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1⁴,⁷.0⁶,¹¹]heptacosa-6(11),7,9,19-tetraene-24-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Vaniprevir is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Vaniprevir is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1 InChI=1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46) |
---|
Synonyms | Value | Source |
---|
21-Tert-butyl-N-{1-[(cyclopropanesulfonyl)-C-hydroxycarbonimidoyl]-2-ethylcyclopropyl}-19-hydroxy-16,16-dimethyl-3,22-dioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1,.0,]heptacosa-6(11),7,9,19-tetraene-24-carboximidate | Generator | 21-Tert-butyl-N-{1-[(cyclopropanesulphonyl)-C-hydroxycarbonimidoyl]-2-ethylcyclopropyl}-19-hydroxy-16,16-dimethyl-3,22-dioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1,.0,]heptacosa-6(11),7,9,19-tetraene-24-carboximidate | Generator | 21-Tert-butyl-N-{1-[(cyclopropanesulphonyl)-C-hydroxycarbonimidoyl]-2-ethylcyclopropyl}-19-hydroxy-16,16-dimethyl-3,22-dioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1,.0,]heptacosa-6(11),7,9,19-tetraene-24-carboximidic acid | Generator |
|
---|
Chemical Formula | C38H55N5O9S |
---|
Average Molecular Weight | 757.94 |
---|
Monoisotopic Molecular Weight | 757.372049545 |
---|
IUPAC Name | 21-tert-butyl-N-{1-[(cyclopropanesulfonyl)carbamoyl]-2-ethylcyclopropyl}-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1^{4,7}.0^{6,11}]heptacosa-6(11),7,9-triene-24-carboxamide |
---|
Traditional Name | 21-tert-butyl-N-[1-(cyclopropanesulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1^{4,7}.0^{6,11}]heptacosa-6(11),7,9-triene-24-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1 |
---|
InChI Identifier | InChI=1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46) |
---|
InChI Key | KUQWGLQLLVFLSM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Cyclic peptides |
---|
Alternative Parents | |
---|
Substituents | - Cyclic alpha peptide
- Macrolactam
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Isoindoline
- Isoindole or derivatives
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine-2-carboxamide
- Benzenoid
- Cyclopropanecarboxylic acid or derivatives
- Carbamic acid ester
- Tertiary carboxylic acid amide
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Pyrrolidine
- Aminosulfonyl compound
- Secondary carboxylic acid amide
- Carboxamide group
- Lactam
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Vaniprevir,1TMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C | 5673.7 | Semi standard non polar | 33892256 | Vaniprevir,1TMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C | 5664.1 | Standard non polar | 33892256 | Vaniprevir,1TMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C | 8005.7 | Standard polar | 33892256 | Vaniprevir,1TMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 5530.3 | Semi standard non polar | 33892256 | Vaniprevir,1TMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 5623.0 | Standard non polar | 33892256 | Vaniprevir,1TMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 7555.7 | Standard polar | 33892256 | Vaniprevir,1TMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C)S(=O)(=O)C1CC1 | 5635.9 | Semi standard non polar | 33892256 | Vaniprevir,1TMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C)S(=O)(=O)C1CC1 | 5693.2 | Standard non polar | 33892256 | Vaniprevir,1TMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C)S(=O)(=O)C1CC1 | 7932.8 | Standard polar | 33892256 | Vaniprevir,1TBDMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C(C)(C)C | 5884.0 | Semi standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C(C)(C)C | 5908.7 | Standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #1 | CCC1CC1(C(=O)NS(=O)(=O)C1CC1)N(C(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)[Si](C)(C)C(C)(C)C | 8007.5 | Standard polar | 33892256 | Vaniprevir,1TBDMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C(C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 5807.5 | Semi standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C(C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 5876.7 | Standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #2 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)N([Si](C)(C)C(C)(C)C)C(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 | 7575.3 | Standard polar | 33892256 | Vaniprevir,1TBDMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1CC1 | 5851.8 | Semi standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1CC1 | 5928.2 | Standard non polar | 33892256 | Vaniprevir,1TBDMS,isomer #3 | CCC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OCC(C)(C)CCCCC1=CC=CC3=C1CN(C3)C(=O)O2)C(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1CC1 | 7958.2 | Standard polar | 33892256 |
|
---|